X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (108) 108
index medicus (96) 96
female (87) 87
male (83) 83
tuberculosis (72) 72
pharmacology & pharmacy (63) 63
infectious diseases (61) 61
adult (56) 56
microbiology (56) 56
pharmacokinetics (51) 51
hiv infections - drug therapy (48) 48
antitubercular agents - therapeutic use (38) 38
pharmacology (37) 37
rifampin (37) 37
tuberculosis - drug therapy (36) 36
pulmonary tuberculosis (35) 35
mycobacterium-tuberculosis (34) 34
child, preschool (33) 33
hiv (33) 33
middle aged (33) 33
children (31) 31
rifampin - therapeutic use (31) 31
antitubercular agents - pharmacokinetics (30) 30
immunology (29) 29
infant (28) 28
south africa (28) 28
population pharmacokinetics (27) 27
adolescent (26) 26
anti-hiv agents - therapeutic use (26) 26
child (26) 26
drug therapy (24) 24
pyrazinamide (24) 24
treatment outcome (24) 24
tuberculosis, pulmonary - drug therapy (24) 24
hiv infections - complications (23) 23
human immunodeficiency virus--hiv (23) 23
anti-hiv agents - pharmacokinetics (22) 22
drug interactions (22) 22
hiv infections - virology (22) 22
young adult (22) 22
antiretroviral therapy (21) 21
rifampin - pharmacokinetics (21) 21
drug therapy, combination (20) 20
medical and health sciences (20) 20
medicin och hälsovetenskap (20) 20
analysis (19) 19
anti-hiv agents - administration & dosage (19) 19
rifampin - administration & dosage (19) 19
rifampicin (18) 18
antitubercular agents - administration & dosage (17) 17
area under curve (17) 17
care and treatment (17) 17
model (17) 17
antituberculosis drugs (16) 16
dosage and administration (16) 16
drugs (16) 16
moxifloxacin (16) 16
mycobacterium tuberculosis - drug effects (16) 16
nevirapine (16) 16
plasma-concentrations (16) 16
tuberculosis - complications (16) 16
isoniazid - therapeutic use (15) 15
lopinavir (15) 15
prospective studies (15) 15
research (15) 15
antiviral agents (14) 14
article (14) 14
chemotherapy (14) 14
efavirenz (14) 14
hiv-infected patients (14) 14
ritonavir (14) 14
therapy (14) 14
antitubercular agents - blood (13) 13
drug administration schedule (13) 13
isoniazid (13) 13
multidrug-resistant tuberculosis (13) 13
nonmem (13) 13
virology (13) 13
adults (12) 12
anti-hiv agents - blood (12) 12
antibiotics, antitubercular - pharmacokinetics (12) 12
antiretroviral drugs (12) 12
basic medicine (12) 12
clinical trials (12) 12
farmaceutiska vetenskaper (12) 12
medicine (12) 12
medicinska och farmaceutiska grundvetenskaper (12) 12
pediatrics (12) 12
pharmaceutical sciences (12) 12
rifampin - blood (12) 12
tuberculosis, multidrug-resistant - drug therapy (12) 12
tuberculosis, pulmonary - microbiology (12) 12
variability (12) 12
antibiotics, antitubercular - therapeutic use (11) 11
cohort studies (11) 11
drug resistance (11) 11
genotype (11) 11
health aspects (11) 11
hiv infection (11) 11
isoniazid - pharmacokinetics (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 11/2013, Volume 208, Issue 9, pp. 1464 - 1473
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 8/2007, Volume 196, Issue 1, pp. s63 - s75
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1599 - 1608
Journal Article
Lancet Respiratory Medicine, The, ISSN 2213-2600, 2017, Volume 5, Issue 4, pp. 291 - 360
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 6, pp. 711 - 720
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2017, Volume 64, Issue 10, pp. 1350 - 1359
Background. There is scant evidence to support target drug exposures for optimal tuberculosis outcomes. We therefore assessed whether... 
pharmacokinetic-pharmacodynamic variability | drug-drug antagonism | minimum inhibitory concentrations | Mycobacterium tuberculosis | tuberculosis treatment outcomes | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | RIFAMPIN | MICROBIOLOGY | IMMUNOLOGY | PHARMACOKINETICS-PHARMACODYNAMICS | PLASMA | BACTERICIDAL ACTIVITY | STERILIZING ACTIVITY | PREDICT | RESISTANCE | PYRAZINAMIDE | OUTCOMES | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Isoniazid - pharmacology | Rifampin - pharmacokinetics | Rifampin - blood | Coinfection - drug therapy | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Tuberculosis, Pulmonary - complications | Microbial Sensitivity Tests | Pyrazinamide - pharmacology | Drug Interactions | Mycobacterium tuberculosis - physiology | Adult | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Drug Therapy, Combination | Isoniazid - antagonists & inhibitors | Antitubercular Agents - therapeutic use | Pyrazinamide - administration & dosage | Isoniazid - pharmacokinetics | Pyrazinamide - pharmacokinetics | Antitubercular Agents - pharmacology | Logistic Models | Treatment Outcome | Pyrazinamide - blood | Coinfection - virology | Mycobacterium tuberculosis - isolation & purification | Coinfection - microbiology | Antitubercular Agents - pharmacokinetics | HIV Infections - complications | Rifampin - pharmacology | Mycobacterium tuberculosis - growth & development | Treatment outcome | Care and treatment | Research | Antibiosis | Analysis | Pulmonary tuberculosis | Major | drug–drug antagonism
Journal Article